 |
86 Diseases |  |
33 Trials |
|
33 Trials |  |
1474 News |  |
| «12...6789101112131415161718» |
- | cilostazol / Generic mfg.
Trial primary completion date: Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI (clinicaltrials.gov) - Oct 27, 2017
P=N/A, N=42, Recruiting, Sponsor: Danish Headache Center
Trial primary completion date: Jun 2017 --> Jun 2018
- | cilostazol / Generic mfg.
Trial completion: Cilostazol After Lower Extremity Arterial Revascularization Trial (clinicaltrials.gov) - Oct 24, 2017
P4, N=20, Completed, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Jun 2017 --> Jun 2018 Active, not recruiting --> Completed
- | cilostazol / Generic mfg., sumatriptan succinate / Generic mfg.
Trial completion: Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers (clinicaltrials.gov) - Oct 19, 2017
P=N/A, N=30, Completed, Sponsor: Danish Headache Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cilostazol / Generic mfg.
Trial primary completion date: Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes (clinicaltrials.gov) - Oct 8, 2017
P4, N=50, Recruiting, Sponsor: Seoul National University Bundang Hospital
Active, not recruiting --> Completed Trial primary completion date: Sep 2017 --> Sep 2018
- | cilostazol / Generic mfg.
Trial primary completion date: A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) (clinicaltrials.gov) - Sep 27, 2017
P2, N=200, Recruiting, Sponsor: National Cerebral and Cardiovascular Center
Trial primary completion date: Sep 2017 --> Sep 2018 Trial primary completion date: Jul 2018 --> Mar 2020
- | cilostazol / Generic mfg.
Trial primary completion date: SILOAM: Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients (clinicaltrials.gov) - Aug 18, 2017
P4, N=951, Recruiting, Sponsor: Korea University Guro Hospital
Trial primary completion date: Jul 2018 --> Mar 2020 Trial primary completion date: Jul 2017 --> Jul 2018
- | cilostazol / Generic mfg.
New P4 trial: Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes (clinicaltrials.gov) - Aug 13, 2017
P4, N=50, Recruiting, Sponsor: Seoul National University Bundang Hospital
- | cilostazol / Generic mfg., sumatriptan succinate / Generic mfg.
Enrollment closed: Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers (clinicaltrials.gov) - Aug 3, 2017
P=N/A, N=30, Active, not recruiting, Sponsor: Danish Headache Center
Trial primary completion date: Jul 2017 --> Jul 2018 Recruiting --> Active, not recruiting
- | cilostazol / Generic mfg.
Journal: Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease. (Pubmed Central) - Jul 26, 2017
Recruiting --> Active, not recruiting The use of guideline-recommended therapies in patients with PAD was much lower than expected, which highlights an opportunity to improve the quality of care in these high-risk patients.
- || cilostazol / Generic mfg., clopidogrel / Generic mfg.
Trial primary completion date: CiloMecT: Pharmacodynamic Study of Cilostazol in Healthy Volunteers (clinicaltrials.gov) - Jul 25, 2017
P1, N=68, Recruiting, Sponsor: Otsuka Pharmaceutical Co., Ltd.
The use of guideline-recommended therapies in patients with PAD was much lower than expected, which highlights an opportunity to improve the quality of care in these high-risk patients. Trial primary completion date: Apr 2017 --> Dec 2017
- ||| clopidogrel / Generic mfg.
Trial completion: Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients (clinicaltrials.gov) - Jul 19, 2017
P=N/A, N=1078, Completed, Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Trial primary completion date: Apr 2017 --> Dec 2017 Active, not recruiting --> Completed
- | cilostazol / Generic mfg.
Review, Journal: Medical management of claudication. (Pubmed Central) - Jul 15, 2017
Exercise is critical for cardiovascular health and highly effective for improving claudication symptoms. Cilostazol may be considered for symptomatic treatment in certain patients.
- | cilostazol / Generic mfg.
Trial primary completion date: Cilostazol After Lower Extremity Arterial Revascularization Trial (clinicaltrials.gov) - Jun 2, 2017
P4, N=20, Active, not recruiting, Sponsor: Wake Forest University Health Sciences
Cilostazol may be considered for symptomatic treatment in certain patients. Trial primary completion date: Apr 2017 --> Aug 2017
- | cilostazol / Generic mfg., sumatriptan succinate / Generic mfg.
New trial: Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers (clinicaltrials.gov) - May 16, 2017
P=N/A, N=30, Recruiting, Sponsor: Danish Headache Center
- | cilostazol / Generic mfg., sumatriptan succinate / Generic mfg.
Trial completion, Trial primary completion date: The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache (clinicaltrials.gov) - May 9, 2017
P=N/A, N=30, Completed, Sponsor: Danish Headache Center
Trial primary completion date: Apr 2017 --> Aug 2017 Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Jun 2016
- ||||||| cilostazol / Generic mfg.
Trial completion: STELLAt: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina (clinicaltrials.gov) - May 4, 2017
P3, N=100, Completed, Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Jun 2016 Recruiting --> Completed
- |||| cilostazol / Generic mfg.
Trial completion: IMPACTonIMT: Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease (clinicaltrials.gov) - Apr 26, 2017
P4, N=342, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- | cilostazol / Generic mfg.
Trial primary completion date: SILOAM: Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients (clinicaltrials.gov) - Apr 25, 2017
P4, N=951, Recruiting, Sponsor: Korea University Guro Hospital
Active, not recruiting --> Completed Trial primary completion date: Jul 2016 --> Jul 2017
- | aspirin / Generic mfg., cilostazol / Generic mfg.
New P4 trial: PASS: The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients (clinicaltrials.gov) - Apr 17, 2017
P4, N=80, Completed, Sponsor: Ajou University School of Medicine
- | cilostazol / Generic mfg.
Enrollment closed: Cilostazol After Lower Extremity Arterial Revascularization Trial (clinicaltrials.gov) - Mar 14, 2017
P4, N=20, Active, not recruiting, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting
- cilostazol / Generic mfg.
Enrollment change, Trial primary completion date: Cilostazol After Lower Extremity Arterial Revascularization Trial (clinicaltrials.gov) - Jan 19, 2017
P4, N=20, Recruiting, Sponsor: Wake Forest University Health Sciences
Recruiting --> Active, not recruiting N=30 --> 20 | Trial primary completion date: Jul 2016 --> Apr 2017
- cilostazol / Generic mfg.
Trial primary completion date: Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=42, Recruiting, Sponsor: Danish Headache Center
N=30 --> 20 | Trial primary completion date: Jul 2016 --> Apr 2017 Trial primary completion date: Dec 2016 --> Jun 2017
- | aspirin / Generic mfg., cilostazol / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: CILO-PER: Cilostazol Following Peripheral Endovascular Procedures (clinicaltrials.gov) - Dec 9, 2016
P3, N=200, Recruiting, Sponsor: Attikon Hospital
Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting | Initiation date: May 2016 --> Dec 2016 | Trial primary completion date: May 2018 --> Dec 2018
- ||||| cilostazol / Generic mfg.
New P4 trial: DORIC: Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? (clinicaltrials.gov) - Dec 5, 2016
P4, N=1885, Recruiting, Sponsor: University of Ioannina
- | cilostazol / Generic mfg.
Trial completion: ESCAPE: Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM (clinicaltrials.gov) - Nov 28, 2016
P3, N=100, Completed, Sponsor: Seoul National University Bundang Hospital
Not yet recruiting --> Recruiting | Initiation date: May 2016 --> Dec 2016 | Trial primary completion date: May 2018 --> Dec 2018 Recruiting --> Completed
- | aspirin / Generic mfg., cilostazol / Generic mfg.
New P4 trial: Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients (clinicaltrials.gov) - Oct 13, 2016
P4, N=116, Not yet recruiting, Sponsor: Kangbuk Samsung Hospital
- ||| aspirin / Generic mfg., cilostazol / Generic mfg.
Enrollment closed, Trial primary completion date: Challenge: Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease (clinicaltrials.gov) - Sep 26, 2016
P4, N=255, Active, not recruiting, Sponsor: Inha University Hospital
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Aug 2018
- cilostazol / Generic mfg.
Trial primary completion date: ESCAPE: Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM (clinicaltrials.gov) - Aug 23, 2016
P3, N=100, Recruiting, Sponsor: Seoul National University Bundang Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Aug 2018 Trial primary completion date: Jul 2016 --> Oct 2016
- | cilostazol / Generic mfg.
New P4 trial: Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) (clinicaltrials.gov) - Jul 12, 2016
P4, N=390, Not yet recruiting, Sponsor: Yonsei University
- isosorbide mononitrate / Generic mfg., cilostazol / Generic mfg.
Enrollment open: Prevent-SVD: Lacunar Intervention Trial 1 (LACI-1) (clinicaltrials.gov) - May 13, 2016
P2, N=60, Recruiting, Sponsor: University of Edinburgh
Trial primary completion date: Jul 2016 --> Oct 2016 Not yet recruiting --> Recruiting
- || aspirin / Generic mfg., cilostazol / Generic mfg.
New P3 trial: CILO-PER: Cilostazol Following Peripheral Endovascular Procedures (clinicaltrials.gov) - May 12, 2016
P3, N=200, Not yet recruiting, Sponsor: Attikon Hospital
- Enrollment open, Trial primary completion date: OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial (clinicaltrials.gov) - Mar 19, 2016
P4, N=1350, Recruiting, Sponsor: The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Nov 2016
- cilostazol / Generic mfg.
Enrollment change, Trial termination: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (clinicaltrials.gov) - Feb 18, 2016
P3, N=26, Terminated, Sponsor: Jong Woo Chung
N=72 --> 26 | Recruiting --> Terminated; Participant enrollment is much delayed. The whole design needs to be revised.
- ||||||| cilostazol / Generic mfg.
Trial completion: STELLA_Ext: Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina (clinicaltrials.gov) - Jan 30, 2016
P3, N=65, Completed, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
The whole design needs to be revised. Recruiting --> Completed
- || aspirin / Generic mfg., cilostazol / Generic mfg.
Trial primary completion date: PICASSO: PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage (clinicaltrials.gov) - Dec 25, 2015
P4, N=1600, Active, not recruiting, Sponsor: Asan Medical Center
Recruiting --> Completed Trial primary completion date: Aug 2015 --> Sep 2016
- || cilostazol / Generic mfg.
Trial primary completion date: PICASSO-IMT: PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study (clinicaltrials.gov) - Dec 24, 2015
P4, N=800, Active, not recruiting, Sponsor: Asan Medical Center
Trial primary completion date: Aug 2015 --> Sep 2016 Trial primary completion date: Aug 2015 --> Sep 2016
- cilostazol / Generic mfg.
Enrollment open, Enrollment change: Cilostazol After Lower Extremity Arterial Revascularization Trial (clinicaltrials.gov) - Dec 17, 2015
P4, N=30, Recruiting, Sponsor: Wake Forest School of Medicine
Trial primary completion date: Aug 2015 --> Sep 2016 Not yet recruiting --> Recruiting | N=10 --> 30
- | cilostazol / Generic mfg.
Trial termination, Trial primary completion date, Adverse events: Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI) (clinicaltrials.gov) - Nov 16, 2015
P4, N=402, Terminated, Sponsor: Seung-Jung Park
Not yet recruiting --> Recruiting | N=10 --> 30 Active, not recruiting --> Terminated | Trial primary completion date: Jan 2016 --> Feb 2015; Low Recruitment
- cilostazol / Generic mfg.
Trial primary completion date: ESCAPE: Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM (clinicaltrials.gov) - Oct 27, 2015
P3, N=100, Recruiting, Sponsor: Seoul National University Bundang Hospital
Active, not recruiting --> Terminated | Trial primary completion date: Jan 2016 --> Feb 2015; Low Recruitment Trial primary completion date: Dec 2016 --> Jul 2016
- cilostazol / Generic mfg.
Trial primary completion date: SILOAM: Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients (clinicaltrials.gov) - Oct 22, 2015
P4, N=951, Recruiting, Sponsor: Korea University Guro Hospital
Trial primary completion date: Dec 2016 --> Jul 2016 Trial primary completion date: Jul 2014 --> Jul 2016
- cilostazol / Generic mfg.
Trial completion: Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease (clinicaltrials.gov) - Oct 15, 2015
P4, N=71, Completed, Sponsor: National Cheng-Kung University Hospital
Trial primary completion date: Jul 2014 --> Jul 2016 Active, not recruiting --> Completed
- ||| cilostazol / Generic mfg., clopidogrel / Generic mfg.
New P1 trial: CiloMecT: Pharmacodynamic Study of Cilostazol in Healthy Volunteers (clinicaltrials.gov) - Sep 18, 2015
P1, N=68, Recruiting, Sponsor: Otsuka Pharmaceutical Co., Ltd.
- cilostazol / Generic mfg.
New trial: Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=42, Recruiting, Sponsor: Danish Headache Center
- isosorbide mononitrate / Generic mfg., cilostazol / Generic mfg.
Trial primary completion date: Prevent-SVD: Lacunar Intervention Trial 1 (LACI-1) (clinicaltrials.gov) - Aug 22, 2015
P2, N=60, Not yet recruiting, Sponsor: University of Edinburgh
Active, not recruiting --> Completed Trial primary completion date: Mar 2017 --> Jun 2017
- cilostazol / Generic mfg.
Trial completion, Trial primary completion date: Induction of Migraine Aura With Cilostazol (clinicaltrials.gov) - Aug 21, 2015
P0, N=16, Completed, Sponsor: Herlev Hospital
Trial primary completion date: Mar 2017 --> Jun 2017 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015
- || clopidogrel / Generic mfg.
Enrollment closed, Trial primary completion date: Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients (clinicaltrials.gov) - Aug 15, 2015
P=N/A, N=1050, Active, not recruiting, Sponsor: Cardiovascular Institute & Fuwai Hospital
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Sep 2016
- | cilostazol / Generic mfg.
New P2 trial: A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) (clinicaltrials.gov) - Jul 8, 2015
P2, N=200, Recruiting, Sponsor: National Cerebral and Cardiovascular Center
- cilostazol / Generic mfg., sumatriptan succinate / Generic mfg.
New trial: The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache (clinicaltrials.gov) - Jul 1, 2015
P=N/A, N=30, Recruiting, Sponsor: Danish Headache Center
- ||||| cilostazol / Generic mfg.
New P4 trial: PICASSO-IMT: PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study (clinicaltrials.gov) - Jun 26, 2015
P4, N=800, Active, not recruiting, Sponsor: Asan Medical Center
- ||||| isosorbide mononitrate / Generic mfg., cilostazol / Generic mfg.
New P2 trial: Prevent-SVD: Lacunar Intervention Trial 1 (LACI-1) (clinicaltrials.gov) - Jun 25, 2015
P2, N=60, Not yet recruiting, Sponsor: University of Edinburgh